The chemical substance with the name "(2E,11α,13E,15S,17S)-11,15-Di-O-tetrahydropyranyl-17,20-diMethyl-9,11,15-trihydroxy-prosta-2,13-diene-1-oic Acid-d3 Methyl Ester (Mixture of Diastereomers)" and CAS number "1316264-00-2" is a complex organic compound belonging to the prostaglandin family, characterized by its multiple hydroxyl groups and specific stereochemistry. This substance features a prostanoid backbone, which is significant in biological systems, particularly in mediating various physiological functions. The presence of tetrahydropyranyl groups indicates that it has been modified to enhance stability or solubility. The diastereomeric mixture suggests that the compound exists in multiple spatial configurations, which can influence its biological activity and interactions. The methyl ester form indicates that the carboxylic acid group has been esterified, potentially affecting its reactivity and pharmacokinetics. Overall, this compound is likely to be of interest in medicinal chemistry and pharmacology, particularly in the development of therapeutics targeting prostaglandin pathways.

(2E,11α,13E,15S,17S)-11,15-Di-O-tetrahydropyranyl-17,20-diMethyl-9,11,15-trihydroxy-prosta-2,13-diene-1-oic Acid-d3 Methyl Ester (Mixture of DiastereoMers)

1316264-00-2: The chemical substance with the name "(2E,11α,13E,15S,17S)-11,15-Di-O-tetrahydropyranyl-17,20-diMethyl-9,11,15-trihydroxy-prosta-2,13-diene-1-oic Acid-d3 Methyl Ester (Mixture of Diastereomers)" and CAS number "1316264-00-2" is a complex organic compound belonging to the prostaglandin family, characterized by its multiple hydroxyl groups and specific stereochemistry. This substance features a prostanoid backbone, which is significant in biological systems, particularly in mediating various physiological functions. The presence of tetrahydropyranyl groups indicates that it has been modified to enhance stability or solubility. The diastereomeric mixture suggests that the compound exists in multiple spatial configurations, which can influence its biological activity and interactions. The methyl ester form indicates that the carboxylic acid group has been esterified, potentially affecting its reactivity and pharmacokinetics. Overall, this compound is likely to be of interest in medicinal chemistry and pharmacology, particularly in the development of therapeutics targeting prostaglandin pathways.

CAS 1316264-00-2

(2E,11α,13E,15S,17S)-11,15-Di-O-tetrahydropyranyl-17,20-diMethyl-9,11,15-trihydroxy-prosta-2,13-diene-1-oic Acid-d3 Methyl Ester (Mixture of DiastereoMers)